2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow FSRT: new trials by email Literature Review of FSRT trials Research Report on FSRT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases FSRT, HA-WBRT-SIB, Bevacizumab - Lung Adenocarcinoma, Brain Metastases | Phase 3 | Recruiting | Sun Yat-sen University | 220 | 2026-03-20 | 2026-04-06 |
| FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma Bevacizumab, FSRT, Whole brain radiotherapy - Multiple Brain Metastases in Lung Adenocarcinoma | Phase 3 | Recruiting | Sun Yat-Sen University Cancer Center | 258 | 2025-06-30 | 2025-12-02 |
Adenocarcinoma of Lung (1) · Brain Neoplasms (1)
Sun Yat-Sen University Cancer Center (1) · Sun Yat-sen University (1)
China (2)
PMID 15254054, PMID 16757720, PMID 16856022, PMID 19801201, PMID 23814264, PMID 25349290, PMID 27458945, PMID 29420112, PMID 30395902, PMID 31569068, PMID 32058845, PMID 32347302